Hyperbolic multivariate feature learning in higher-order heterogeneous networks for drug–disease prediction

IF 6.1 2区 医学 Q1 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE
Jiamin Li , Jianrui Chen , Junjie Huang , Xiujuan Lei
{"title":"Hyperbolic multivariate feature learning in higher-order heterogeneous networks for drug–disease prediction","authors":"Jiamin Li ,&nbsp;Jianrui Chen ,&nbsp;Junjie Huang ,&nbsp;Xiujuan Lei","doi":"10.1016/j.artmed.2025.103090","DOIUrl":null,"url":null,"abstract":"<div><div>New drug discovery has always been a costly, time-consuming process with a high failure rate. Repurposing existing drugs offers a valuable alternative and reduces the risks associated with developing new drugs. Various experimental methods have been employed to facilitate drug repositioning; however, associations prediction between drugs and diseases through biological experiments is both expensive and time-consuming. Consequently, it is imperative to develop efficient and highly precise computational methods for predicting these associations. Based on this, we propose a drug–disease associations prediction method based on <span><math><mi>H</mi></math></span>yperbolic <span><math><mi>M</mi></math></span>ultivariate feature <span><math><mi>L</mi></math></span>earning in <span><math><mi>H</mi></math></span>igh-order <span><math><mi>H</mi></math></span>eterogeneous Networks for Drug–Disease Prediction, called <span><math><mi>H</mi></math></span><sup>3</sup>ML. Our approach begins by mining high-order information from protein–disease and drug–protein networks to construct high-order heterogeneous networks. Subsequently, we employ multivariate feature learning to create hyperbolic representations, and then enhance the features of the heterogeneous network. Finally, we utilize a hyperbolic graph attention network in the hyperbolic space to aggregate neighbor information and perform the final prediction task. In addition, we evaluate the performance of <span><math><mi>H</mi></math></span><sup>3</sup>ML by comparing it with some state-of-the-art methods across different datasets. The case study further validate the effectiveness of <span><math><mi>H</mi></math></span><sup>3</sup>ML. Our implementation will be publicly available at: <span><span>https://github.com/jianruichen/H-3ML</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":55458,"journal":{"name":"Artificial Intelligence in Medicine","volume":"162 ","pages":"Article 103090"},"PeriodicalIF":6.1000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Artificial Intelligence in Medicine","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0933365725000259","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE","Score":null,"Total":0}
引用次数: 0

Abstract

New drug discovery has always been a costly, time-consuming process with a high failure rate. Repurposing existing drugs offers a valuable alternative and reduces the risks associated with developing new drugs. Various experimental methods have been employed to facilitate drug repositioning; however, associations prediction between drugs and diseases through biological experiments is both expensive and time-consuming. Consequently, it is imperative to develop efficient and highly precise computational methods for predicting these associations. Based on this, we propose a drug–disease associations prediction method based on Hyperbolic Multivariate feature Learning in High-order Heterogeneous Networks for Drug–Disease Prediction, called H3ML. Our approach begins by mining high-order information from protein–disease and drug–protein networks to construct high-order heterogeneous networks. Subsequently, we employ multivariate feature learning to create hyperbolic representations, and then enhance the features of the heterogeneous network. Finally, we utilize a hyperbolic graph attention network in the hyperbolic space to aggregate neighbor information and perform the final prediction task. In addition, we evaluate the performance of H3ML by comparing it with some state-of-the-art methods across different datasets. The case study further validate the effectiveness of H3ML. Our implementation will be publicly available at: https://github.com/jianruichen/H-3ML.
求助全文
约1分钟内获得全文 求助全文
来源期刊
Artificial Intelligence in Medicine
Artificial Intelligence in Medicine 工程技术-工程:生物医学
CiteScore
15.00
自引率
2.70%
发文量
143
审稿时长
6.3 months
期刊介绍: Artificial Intelligence in Medicine publishes original articles from a wide variety of interdisciplinary perspectives concerning the theory and practice of artificial intelligence (AI) in medicine, medically-oriented human biology, and health care. Artificial intelligence in medicine may be characterized as the scientific discipline pertaining to research studies, projects, and applications that aim at supporting decision-based medical tasks through knowledge- and/or data-intensive computer-based solutions that ultimately support and improve the performance of a human care provider.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信